Phil Tennant

CIK 2030874 · View on SEC EDGAR ↗

Insider

First SEC filing: May 27, 2026 · Latest: May 27, 2026

On this page

Insider at

Insider transactions

1 buys (P) 1 sells (S) Net: $-110,506 + 17 non-open-market transactions below Avg return of open purchases vs now: 103.9% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

17 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 28, 2026 PGEN S 30,272 $4.36 $131,986 139,369 Direct -17.84% Disposed 67.4% (price as of 2026-08-21)
Sept. 29, 2025 PGEN P 6,000 $3.58 $21,480 65,031 Direct +10.16% Acquired 103.9% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 23, 2026 PGEN Restricted Stock Units Common Stock (62,500) 62,500 Disposed
April 20, 2026 PGEN Restricted Stock Units Common Stock (115,000) 115,000 Acquired
April 20, 2026 PGEN Option to Purchase Common Stock (Right to Buy) Common Stock (385,000) $4.11 April 20, 2036 385,000 Acquired
March 18, 2026 PGEN Restricted Stock Units Common Stock (42,110) 42,110 Disposed
March 18, 2026 PGEN Restricted Stock Units Common Stock (42,110) 42,110 Acquired
Sept. 12, 2025 PGEN Performance Stock Units Common Stock (25,000) 25,000 Acquired
June 26, 2025 PGEN Restricted Stock Units Common Stock (125,000) 125,000 Acquired
May 23, 2025 PGEN Option to Purchase Common Stock (Right to Buy) Common Stock (250,000) $1.37 May 23, 2035 250,000 Acquired
May 16, 2025 PGEN Restricted Stock Units Common Stock (66,441) 66,441 Disposed
April 17, 2025 PGEN Restricted Stock Units Common Stock (66,441) 66,441 Acquired
July 22, 2024 PGEN Option to Purchase Common Stock (Right to Buy) Common Stock (200,000) $1.61 July 22, 2034 200,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PGEN

Chief Commercial Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $510,000 $271,103 $267,300 $137,700 $43,853 $1,229,956
2024 $215,769 $28,250 $252,660 $21,658 $518,337

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.